tiprankstipranks
Trending News
More News >
Simcere Pharmaceutical Group Limited (HK:2096)
:2096
Hong Kong Market

Simcere Pharmaceutical Group Limited (2096) Income Statement

Compare
4 Followers

Simcere Pharmaceutical Group Limited Income Statement

Last quarter (Q2 2024), Simcere Pharmaceutical Group Limited's total revenue was ¥1.56B, a decrease of -7.87% from the same quarter last year. In Q2, Simcere Pharmaceutical Group Limited's net income was ¥228.30M. See Simcere Pharmaceutical Group Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
¥ 6.61B¥ 6.32B¥ 5.00B¥ 4.51B¥ 5.04B
Gross Profit
¥ 4.98B¥ 5.00B¥ 3.92B¥ 3.61B¥ 4.15B
Operating Expenses
¥ 4.27B¥ 4.42B¥ 3.70B¥ 3.02B¥ 3.01B
Depreciation and Amortization
¥ 309.59M¥ 283.65M¥ 251.81M¥ 222.33M¥ 162.51M
EBITDA
¥ 1.08B¥ 1.09B¥ 939.71M¥ 787.99M¥ 1.36B
Operating Income
¥ 711.80M¥ 862.50M¥ 687.90M¥ 565.66M¥ 1.17B
Other Income/Expenses
¥ 28.24M¥ 25.65M¥ -46.75M¥ -121.75M¥ -89.50M
Pretax Income
¥ 740.04M¥ 888.15M¥ 1.40B¥ 805.09M¥ 1.08B
Net Income
¥ 714.76M¥ 930.87M¥ 1.51B¥ 669.53M¥ 1.00B
Per Share Metrics
Basic EPS
¥ 0.27¥ 0.40¥ 0.58¥ 0.26¥ 0.39
Diluted EPS
¥ 0.27¥ 0.40¥ 0.58¥ 0.26¥ 0.39
Weighted Average Shares Outstanding
2.61B 2.61B 2.61B 2.61B 2.61B
Weighted Average Shares Outstanding (Diluted)
2.61B 2.62B 2.61B 2.61B 2.61B
Currency in CNY

Simcere Pharmaceutical Group Limited Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis